Ngày 19/01/1988 | 10:13.

Complete revascularisation is rarely achieved in patients with multivessel coronary artery disease (CAD) and cardiogenic shock related to acute myocardial infarction (MI). This is the conclusion of a study evaluating the predictive value of the residual SYNTAX score in patients with cardiogenic shock. Findings from the study were published in the Journal of the American College of Cardiology (JACC) in January, with the authors concluding that the residual SYNTAX score is independently associated with early and late mortality.

Ngày 16/01/1988 | 08:16.

Robocath has announced the successful completion of the first remote robotic-assisted percutaneous coronary intervention (PCI) procedure in Europe, carried out by Eric Durand at the Rouen Medical Training Center, Rouen, France and Rémi Sabatier, Caen University Hospital, Caen, France—spanning 75 miles between the two locations.

Ngày 15/01/1988 | 10:41.

Inari Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the FlowTriever system for the treatment of clot in transit (CIT) in the right atrium.

Ngày 13/01/1988 | 11:09.

A recent network meta-analysis shows that, in failing arteriovenous fistulas (AVFs) with outflow stenosis, drug-coated balloon (DCB) angioplasty is “significantly superior” to plain balloon angioplasty, presenting an improved six-month failure rate. However, Gregory Tripsianis (Democritus University, Alexandroupolis, Greece) and colleagues stress that the effectiveness of DCB angioplasty in the long term “deserves further investigation”.

Ngày 08/01/1988 | 09:33.

BioVentrix has announced that heart failure specialist Jerry Estep (Cleveland Clinic, Cleveland, USA) has been appointed as co-principal investigator of the pivotal ALIVE Trial studying LIVE Therapy using the Revivent TC transcatheter ventricular enhancement system. He joins co-principal investigators Gregg Stone of New York’s Mount Sinai Health System (New York, USA) and Andrew Wechsler of the Drexel University College of Medicine (Philadelphia, USA) in overseeing the trial.

Ngày 07/01/1988 | 01:26.

VDYNE has announced today that it has secured a US$21 million Series C financing, proceeds of which will fund first-in-human studies of its tricuspid valve replacement device and delivery system. The financing round was supported by existing investors, including Jean Boulle Medtech, together with significant participation from a large, global medical device company.

Ngày 04/01/1988 | 10:18.

A recent systematic review found that “carefully designed and structured” simulation-based training (SBT) in open vascular surgery is effective and can improve technical skills, especially in less experienced trainees. However, authors Jonathan Lawaetz (Rigshospitalet, Copenhagen, Denmark) and colleagues note that the supporting evidence “lacks homogeneity in the reporting standards and types of simulations”. Pass/fail standards that support proficiency-based learning and studies investigating skills transfer “should be the focus on future studies,” they write.

Ngày 31/12/2020 | 09:45.

Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the progress made in treatment of cardiovascular disease, and considers how US healthcare practitioners can learn from their overseas colleagues in the use of coronary computed tomography angiogram (CTA), which he describes as the “gold standard” diagnostic technique in many countries.

Ngày 30/12/2020 | 09:55.

Okami Medical has revealed the expansion of its LOBO vascular occlusion system product line with US Food and Drug Administration (FDA) 510(k) clearance of the LOBO-5 vascular occluder.

Ngày 29/12/2020 | 08:56.

Speaking at the Virtual Aortic Surgery How to Do It (HTDI) Highlights conference (17–18 December), Stéphan Haulon (Hôpital Marie Lannelongue, GHPSJ, Paris, France) discussed total endovascular treatment of the aortic arch in chronic dissections. Detailing global experience using three-vessel inner branch stent grafts for this procedure, Haulon highlighted good technical success and low morbidity and mortality rates. However, he also stressed that the high number of secondary procedures required remains the “Achilles’ heel” of the technique, and that larger experiences and longer follow-up are mandated.

Ngày 28/12/2020 | 01:38.

Edwards Lifesciences has announced that the first patient has been treated in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the investigational Harpoon Beating Heart Mitral Valve Repair System in the USA and Canada. The Harpoon system is used to treat severe degenerative mitral valve regurgitation. The procedure took place at the University of Maryland Medical Center, Baltimore, USA.

Ngày 23/12/2020 | 01:27.

Edwards Lifesciences has announced that Health Canada has approved the expanded use of the Edwards Sapien 3 and Sapien 3 Ultra transcatheter heart valves for the transfemoral treatment of patients diagnosed with severe symptomatic aortic stenosis who are at low risk for open-heart surgery. The Sapien 3 valves are the first transcatheter aortic valve implantation (TAVI) systems to have this indication in Canada.

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP